This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
CADTH. AmniSure versus fern testing to assess the rupture of fetal membranes in pregnant women: a review of the comparative accuracy, cost-effectiveness, and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). 2012
Evidence suggests that AmniSure is an accurate method for detecting rupture of fetal membranes, but studies examining performance compared with fern testing are limited in number. No cost-effectiveness evidence or evidence-based guidelines were identified.
Subject indexing assigned by CRD
Amniotic Fluid; Diagnostic Techniques, Obstetrical and Gynecological; Females; Fetal Membranes, Premature Rupture; Predictive Value of Tests; Pregnancy
Country of organisation
An English language summary is available.
Address for correspondence
Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, K1S 5S8 Ottawa, Ontario Canada Email: firstname.lastname@example.org
Date abstract record published